Plasma exosome microRNAs are indicative of breast cancer BN Hannafon, YD Trigoso, CL Calloway, YD Zhao, DH Lum, AL Welm, ... Breast cancer research 18, 1-14, 2016 | 562 | 2016 |
Intercellular communication by exosome-derived microRNAs in cancer BN Hannafon, WQ Ding International journal of molecular sciences 14 (7), 14240-14269, 2013 | 554 | 2013 |
Chloroquine is a zinc ionophore J Xue, A Moyer, B Peng, J Wu, BN Hannafon, WQ Ding PloS one 9 (10), e109180, 2014 | 304 | 2014 |
Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA) BN Hannafon, KJ Carpenter, WL Berry, R Janknecht, WC Dooley, ... Molecular cancer 14, 1-13, 2015 | 233 | 2015 |
Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer BN Hannafon, P Sebastiani, A de las Morenas, J Lu, CL Rosenberg Breast cancer research 13, 1-14, 2011 | 200 | 2011 |
Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer YF Xu, BN Hannafon, YD Zhao, RG Postier, WQ Ding Oncotarget 8 (44), 77028, 2017 | 169 | 2017 |
Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria T Liu, B Hannafon, L Gill, W Kelly, D Benbrook Molecular cancer therapeutics 6 (6), 1814-1822, 2007 | 110 | 2007 |
Disulfiram's anticancer activity: evidence and mechanisms Y Jiao, B N Hannafon, WQ Ding Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 101 | 2016 |
miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study BN Hannafon, A Cai, CL Calloway, YF Xu, R Zhang, KM Fung, WQ Ding BMC cancer 19, 1-12, 2019 | 100 | 2019 |
Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists DM Benbrook, SA Kamelle, SB Guruswamy, SA Lightfoot, TL Rutledge, ... Investigational new drugs 23, 417-428, 2005 | 68 | 2005 |
The origin of exosomal miR-1246 in human cancer cells YF Xu, BN Hannafon, U Khatri, A Gin, WQ Ding RNA biology 16 (6), 770-784, 2019 | 63 | 2019 |
Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells BN Hannafon, AL Gin, YF Xu, M Bruns, CL Calloway, WQ Ding Cell Communication and Signaling 17, 1-13, 2019 | 58 | 2019 |
microRNA regulation of human pancreatic cancer stem cells YF Xu, BN Hannafon, WQ Ding Stem cell investigation 4, 2017 | 43 | 2017 |
Cancer stem cells and exosome signaling BN Hannafon, WQ Ding Stem cell investigation 2, 2015 | 35 | 2015 |
Zinc protoporphyrin suppresses cancer cell viability through a heme oxygenase-1-independent mechanism: The involvement of the Wnt/β-catenin signaling pathway S Wang, JE Avery, BN Hannafon, SE Lind, WQ Ding Biochemical pharmacology 85 (11), 1611-1618, 2013 | 32 | 2013 |
Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions Y Jiao, BN Hannafon, RR Zhang, KM Fung, WQ Ding Oncotarget 8 (11), 17908, 2017 | 31 | 2017 |
SRSF1 regulates exosome microRNA enrichment in human cancer cells YF Xu, X Xu, A Gin, JD Nshimiyimana, BHM Mooers, M Caputi, ... Cell Communication and Signaling 18, 1-13, 2020 | 29 | 2020 |
Functional role of miRNAs in the progression of breast ductal carcinoma in situ BN Hannafon, WQ Ding The American Journal of Pathology 189 (5), 966-974, 2019 | 27 | 2019 |
Characterization of docosahexaenoic acid (DHA)-induced heme oxygenase-1 (HO-1) expression in human cancer cells: the importance of enhanced BTB and CNC homology 1 (Bach1 … S Wang, BN Hannafon, RF Wolf, J Zhou, JE Avery, J Wu, SE Lind, ... The journal of nutritional biochemistry 25 (5), 515-525, 2014 | 25 | 2014 |
miRNAs as biomarkers for predicting the progression of ductal carcinoma in situ BN Hannafon, WQ Ding The American Journal of Pathology 188 (3), 542-549, 2018 | 23 | 2018 |